Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.

PUBLICATIONS

350+

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Miller et al.

  • Nature Immunology
  • March 2019

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.

  • Nature Medicine
  • December 2018

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Erhart et al.

  • Acta Neuropathologica
  • December 2018

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank et al.

  • Nature Medicine
  • November 2018

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Naing et al.

  • Cancer Cell
  • November 2018

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Tarhini et al.

  • Journal for ImmunoTherapy of Cancer
  • October 2018

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Ruella et al.

  • Nature Medicine
  • October 2018

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

Paulson et al.

  • Nature Communications
  • Papers
  • September 2018

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

Escobar et al.

  • Nature
  • Papers
  • July 2018
back_to_top